Skip to main content
OpenTrials
Completed

NCT Number: NCT01111201

International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel.

Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoma Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Sloan Kettering Cancer Center

New York, 10065, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hematopoietic Stem Cell Transplant (HSCT) recipients
  • Age >18 years
  • Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3
  • Female age >18 years and current or past history of breast cancer
  • Received systemic chemotherapy in the last five years
  • Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3
  • Age >18 years and current or past history of lymphoma
  • Received systemic chemotherapy within 5 years
  • Had active disease at any time within the last 5 years

Exclusion criteria

  • Patients age< 18 years
  • Breast cancer and lymphoma patients in clinical remission in the past 5 years
  • Patients unable to fill the questionnaire due to language barriers

Treatment and study plan

Questionnaires

Behavioral

The intervention is a self-administered anonymous questionnaire that is voluntarily completed by the patient. Questions in Section One will cover general information about the patient including gender, age, race, country of birth, current zip code of residence, and level of education. Questions in Section Two will cover information regarding the cancer (breast/lymphoma) or transplant (allogeneic/ autologous). Questions in Section Three will cover travel history including the frequency of travel outside the United States and Canada in the last 5 years. Questions in Sections Four through Seven will obtain information about their last trip outside the United States and Canada.

Primary outcomes

  1. To determine the frequency of international travel of the targeted patients in the last 5 years.

    Time frame: once at the time of the clinic visit

Secondary outcomes

  1. To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.

    Time frame: once at the time of the clinic visit

  2. To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics.

    Time frame: once at the time of the clinic visit

  3. To obtain detailed information about their last international trip including

    Time frame: once at the time of the clinic visit

  4. To assess the adequacy of the questionnaire instructions

    Time frame: once at the time of the clinic visit

Sponsors and collaborators

Lead sponsor

Memorial Sloan Kettering Cancer Center

Other

Registry information

Official study title

Pilot Survey to Assess International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Apr 27, 2010
Registry last updated
Jun 1, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.